Impact of the neutrophil-to-lymphocyte ratio on patients with locally advanced non-small cell lung cancer who suffer radiation pneumonitis during the course of induction chemoradiotherapy followed by surgery.

Autor: Kubo Y; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Yamamoto H; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. h.yamamoto@med.shimane-u.ac.jp.; Center for Clinical Genetics and Genomic Medicine, Shimane University Hospital, 89-1 Enya-Cho, Izumo, Shimane, 693-8501, Japan. h.yamamoto@med.shimane-u.ac.jp., Matsubara K; Organ Transplant Center, Okayama University Hospital, Okayama, Japan., Hashimoto K; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Tanaka S; Organ Transplant Center, Okayama University Hospital, Okayama, Japan., Shien K; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan., Suzawa K; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Miyoshi K; Department of Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan., Okazaki M; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Sugimoto S; Organ Transplant Center, Okayama University Hospital, Okayama, Japan., Katsui K; Division of Radiation Oncology, Department of Radiology, Kawasaki Medical School, Kurashiki, Japan., Hiraki T; Department of Radiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Kiura K; Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan., Toyooka S; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Publikováno v: Surgery today [Surg Today] 2024 Sep; Vol. 54 (9), pp. 995-1004. Date of Electronic Publication: 2024 Mar 07.

Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer.

Autor: Kamitani N; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan., Watanabe K; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan. w.kenta.1986@gmail.com., Ikeda N; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan., Kawata Y; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan., Tokiya R; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan., Hayashi T; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan., Miyaji Y; Department of Urology, Kawasaki Medical School, Kurashiki, Okayama, Japan., Tamada T; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan., Katsui K; Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan.

Publikováno v: Japanese journal of radiology [Jpn J Radiol] 2024 Nov; Vol. 42 (11), pp. 1322-1329. Date of Electronic Publication: 2024 Jun 29.

Long-term outcomes of salvage transurethral high-dose-rate brachytherapy combined with external beam radiation therapy for anastomotic recurrence of prostate cancer after radical prostatectomy: A retrospective analysis.

Autor: Watanabe K; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan., Kamitani N; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan. Electronic address: kamitani@med.kawasaki-m.ac.jp., Ikeda N; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan., Kawata Y; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan., Tokiya R; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan., Hayashi T; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan., Miyaji Y; Department of Urology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan., Tamada T; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan., Katsui K; Department of Radiology, Kawasaki Medical School, Kurashiki City, Okayama 701-0192, Japan.

Publikováno v: Brachytherapy [Brachytherapy] 2024 Mar-Apr; Vol. 23 (2), pp. 179-187. Date of Electronic Publication: 2024 Jan 20.

Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer

Autor: Katsui, K., Ogata, T., Watanabe, K., Yoshio, K., Masahiro Kuroda, Hiraki, T., Kiura, K., Maeda, Y., Toyooka, S., Kanazawa, S.

Publikováno v: Scopus-Elsevier

Palliative concurrent chemoradiotherapy (CCRT) is often administered to patients with stage III non-small cell lung cancer (NSCLC). We investigated the clinical outcomes of patients receiving palliative CCRT for NSCLC. Data of patients with NSCLC who

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5f4491268265b1af6721dcbfb7eac3e7
https://ousar.lib.okayama-u.ac.jp/62218

Corrigendum to ‘Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study’: [ESMO Open Volume 6, Issue 4, August 2021, 100191]

Autor: Hotta, K., Saeki, S., Yamaguchi, M., Harada, D., Bessho, A., Tanaka, K., Inoue, K., Gemba, K., Shiojiri, M., Kato, Y., Ninomiya, T., Kubo, T., Kishimoto, J., Shioyama, Y., Katsui, K., Sasaki, J., Kiura, K., Sugio, K.

Publikováno v: ESMO Open

The role of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) induction coupled with standard concurrent chemoradiotherapy (CRT) is unclear in unresectable, stage III, EGFR-mutant non-small-cell lung cancer (NSCLC). Therefore, a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7406ecb6cf587b07b1da2300697dbd47
https://europepmc.org/articles/PMC9263404/